Sign Up to like & get
recommendations!
0
Published in 2020 at "International immunopharmacology"
DOI: 10.1016/j.intimp.2020.106890
Abstract: Therapeutic options for Epstein-Barr virus (EBV)-associated post-transplantation lymphoproliferative diseases (PTLD) are currently limited, accompanying with some off-target toxicities. We previously demonstrated that early recovery of Vδ2+ T cells inversely correlated to EBV reactivation after allogeneic…
read more here.
Keywords:
lymphoproliferative cells;
vpa;
cells ebv;
valproic acid ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Cancers"
DOI: 10.3390/cancers15061914
Abstract: Simple Summary Primary infection with the Epstein–Barr virus (EBV), one of the most common human viruses worldwide, mainly occurs in early childhood without causing symptoms but, especially when delayed into adolescence, it may lead to…
read more here.
Keywords:
infection;
infection related;
role cells;
ebv infection ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Viruses"
DOI: 10.3390/v13020300
Abstract: A vast majority of the population worldwide are asymptomatic carriers of Epstein-Barr Virus (EBV). However, some infected individuals eventually develop EBV-related cancers, including Nasopharyngeal Carcinoma (NPC). NPC is one of the most common EBV-associated epithelial…
read more here.
Keywords:
ebv infection;
ebv;
ebv associated;
cells ebv ... See more keywords